Trending now
Results for
Results for
Create your own feed
• 200 COVID-19 patients in Manila to benefit from 2,000 vials of antiviral drug remdesivir purchased by city, Mayor Isko Moreno says
Share
Zydus Cadila Launches "Most Affordable" COVID-19 Drug Remdesivir In India Read more here:
Manila has acquired 2,000 vials of the antiviral drug remdesivir for the treatment of active COVID-19 cases, Mayor Isko Moreno announced Thursday.
The local government of Manila has procured 2,000 vials of remdesivir, an investigational #COVID19 treatment drug, says Mayor Isko Moreno. He adds that the FDA has approved the use of the antiviral drugs in 6 district hospitals in the city.
Gilead Sciences criticized for expensive pricing of its COVID-fighting antiviral drug, remdesivir.
Zydus Cadila launches India's least expensive version of 'Remdesivir' amid reported shortage
A citizen advocacy organization is pressing Gilead to pursue GS-441524, a compound that is chemically similar to remdesivir.
Trials of Gilead’s remdesivir in #Covid19 not diverse enough, experts write. From @biotechvisigoth @medcitynews $GILD
Coronavirus Briefing: Remdesivir makes it official, predictions for winter abound, “sober curiosity” falls
Loading
#FakeNews Will Bury THIS #Hydroxychloroquine Study ▶️Mortality Cut In HALF In Sick Hospitalized Patients ▶️NO Cardiac Arrythmias#FauciTheFraud remdesivir'>Pushed Expensive Minimally Remdesivir For Profit How Many Lives Were Lost⁉️ @realDonaldTrump
"We found that of 11 members reporting links to a drug company, nine of them named relationships to remdesivir’s maker Gilead. Seven more, including two of the committee’s leaders, have ties to Gilead beyond the 11 months they had to disclose. 2 were on Gilead’s advisory board."
New York promised to help states in need as we were helped when we needed it. Today we pay it forward. Tomorrow we will deliver Remdesivir to Florida to help care for COVID patients. The people of NY stand shoulder to shoulder with Americans fighting this virus.
Dr. Fauci speaks on the clinical trial for potential coronavirus treatment drug remdesivir: “What it has proven is that a drug can block this virus ... This drug happens to be blocking an enzyme that the virus uses."
As Gilead's stock price rises on reports of remdesivir, remember that the drug was developed with a $37.5 million grant from the federal government paid for by the taxpayers. Once again, Big Pharma is set to profit on the taxpayer's dime.
Remdesivir costs less than $10 to manufacture. @GileadSciences is charging $3,100 for it. Taxpayers spent $70 million to develop this drug. Coronavirus has killed 130,000 Americans. It's time to take control of this patent and provide remdesivir to all who need it.
Remdesivir, a potential treatment for coronavirus, has boosted Gilead's stock price in recent days. But here's the catch: Remdesivir was developed with taxpayer funding through CDC and NIH. No drug that was developed with public dollars should be used to pad pharma profits.
Loading